Streetbeat News

Earnings

KMDA

Kamada reported Q1 earnings of $0.04 per share, beating the analyst consensus estimate of $0.02 by 100%. However, quarterly sales of $30.71 million missed the estimate of $34.30 million by 10.47%.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 11:15 am

CLGN

CollPlant Biotechnologies (NASDAQ:CLGN) reported Q1 earnings with in-line EPS of $-0.29 and revenue up $367 thousand from the same period last year. Last quarter, the company missed EPS by $0.04, followed by a 0.0% increase in share price the next day.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 11:15 am

PPG

PPG has set a target of 2% to 4% annual organic sales growth and 8% to 12% annual adjusted EPS growth through 2026.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 11:12 am

BZ

Kanzhun Ltd expects Q2 revenue to be between $209.0M and $213.4M, surpassing the consensus estimate of $207.54M.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 11:10 am

PLCE

Children's Place expects Q2 revenue of $340M-$345M and an adjusted EPS of $(2.15)-$(2.20).

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 11:09 am

CLGN

CollPlant Biotechnologies reported Q1 losses of $(0.29) per share, in line with analyst estimates, and sales of $433K, beating the $240K estimate by 80.42%. This represents a 556.06% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 11:08 am

BZ

Kanzhun (NASDAQ:BZ) reported Q1 earnings with an EPS of $0.08, beating estimates by 33.33%. Revenue was up $6.53 million from the same period last year. The company has a history of beating earnings estimates, which has previously led to share price increases.

Portfolio Pulse from Benzinga Insights

May 24, 2023 | 11:08 am

PLCE

Children's Place forecasts FY23 revenue of $1.575B-$1.59B, lower than the estimated $1.65B, and adjusted EPS of $1.00-$1.50, below the $2.34 estimate.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 11:07 am

BZ

Kanzhun reported Q1 earnings of $0.08 per share, beating the analyst estimate of $0.06 by 33.33%. Sales reached $186.03M, surpassing the estimate of $176.43M by 5.44%.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 11:07 am

WOOF

Petco Health and Wellness has reaffirmed its FY23 guidance, projecting net revenue of $6.15B-$6.275B and adjusted EPS of $0.40-$0.48, which is in line with the consensus estimates of $6.27B and $0.45 respectively.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 11:07 am